History Says This Low-Cost Investment Could Outperform Anthropic -- and You Might Already Own It

Anthropic is reportedly targeting a $100 billion IPO raise, potentially in November, following SpaceX's $86.7 billion June IPO. The article cautions that high-profile IPO performance is unpredictable, citing Lineage's 53% decline since its 2024 listing and SpaceX's current underperformance versus the S&P 500. It favors Vanguard's S&P 500 ETF (VOO), which has $1.8 trillion in assets, a 0.03% expense ratio, and an 11.3% annualized return over the past 20 years.

Analysis

The investable signal is not the retail argument for passive exposure; it is the prospective repricing of private-AI comparables and the liquidity draw from a very large new issuance. The claimed transaction terms and timing require independent verification through an S-1/F-1 and exchange filings before positioning: absent those, this is sentiment rather than a fundamental catalyst. If validated, a $100B primary raise would likely absorb risk capital from late-stage AI vehicles and force public-market investors to benchmark AI valuations against a company with unusually high compute intensity and still-unproven long-run gross margins.

AMZN is the clearest second-order beneficiary if Anthropic's model training and inference commitment translates into contracted AWS consumption; the relevant read-through is not IPO proceeds but disclosures on remaining performance obligations, AWS growth, and capex monetization over the next 1-3 quarters. NVDA could initially benefit from a renewed AI-capex narrative, but it also faces the sharper relative risk: a public valuation that exposes weak AI application-layer unit economics would shift attention from GPU demand to customers' return on invested capital. META is comparatively insulated because its AI spend is funded by an established advertising cash-flow engine, making it a potential relative winner if the market de-rates externally financed AI developers.

Consensus is likely to treat a marquee AI listing as uniformly bullish for the AI complex. The more contrarian outcome is a post-listing lock-up and price-discovery period that compresses software/AI multiples, particularly where revenue is small relative to compute commitments; this would favor profitable platform exposure over speculative AI baskets. Over 6-18 months, index inclusion is not a catalyst by itself: any forced-buying effect occurs only after sustained eligibility, profitability, and index-committee criteria are met, while the company-specific execution risk remains with early holders.

Key Decisions for Investors

• No direct IPO position until a filed prospectus establishes revenue concentration, cloud/compute commitments, cash burn, share count, and lock-up terms. Treat confirmation of those disclosures as the entry trigger rather than media-reported valuation.
• For a 1-3 month relative-value expression, consider long AMZN / short an equal-dollar high-multiple AI software basket (IGV or selected unprofitable AI names) only if AWS backlog or management commentary confirms incremental Anthropic-related demand. Target 10-15% relative upside; exit if AWS growth decelerates or capex rises without improving operating-margin outlook.
• Maintain NVDA exposure only with downside protection around any IPO filing and first trading window; use a 3-6 month collar rather than adding outright. The thesis is falsified if customer disclosures show training demand converting to materially lower inference utilization or if hyperscaler capex guidance is cut.
• Prefer META over externally financed AI developers for the next 6-18 months as a quality AI proxy: its funding model can sustain investment through a private-AI valuation reset. Reassess if ad pricing or operating-margin guidance deteriorates enough to remove the self-funded-capex advantage.